v3.26.1
Statements of Operations - USD ($)
12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
OPERATING EXPENSES    
Research and development $ 3,629,785 $ 1,414,928
General and administrative 5,137,056 3,081,896
Total operating expenses 8,766,841 4,496,824
Loss from operations (8,766,841) (4,496,824)
OTHER EXPENSE, NET    
Interest income 1,078
Interest expense (6,619) (18,029)
Total other expense, net (5,541) (18,029)
NET LOSS (8,772,382) (4,514,853)
Dividends on preferred shares (117,022)
Deemed dividend on warrant modification issued with preferred shares (473,209)
NET LOSS AVAILABLE TO COMMON SHARES $ (8,772,382) $ (5,105,084)
Basic net loss per common share $ (2.63) $ (11.32)
Diluted net loss per common share $ (2.63) $ (11.32)
Basic weighted average common shares outstanding 3,337,143 450,799
Diluted weighted average common shares outstanding 3,337,143 450,799